4-[(4-methoxybenzylidene)amino]benzenesulfonamide | 66667-56-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-[(4-methoxybenzylidene)amino]benzenesulfonamide
• 英文别名: N-(4-Methoxybenzylidene)-4-sulfamoylaniline；4-[(4-methoxyphenyl)methylideneamino]benzenesulfonamide
• CAS: 66667-56-9
• 化学式: C₁₄H₁₄N₂O₃S
• mdl: MFCD00512250
• 分子量: 290.343
• InChiKey: MLUHDVSELBSKPI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  90.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-[(4-methoxybenzylidene)amino]benzenesulfonamide 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 反应 25.0h， 以70%的产率得到4-[(4-methoxybenzyl)amino]benzenesulfonamide
  参考文献：
  名称：

  具有对人碳酸酐酶同工型I，II，IX和XII的抑制活性的4-氨磺酰基苯基-苄胺衍生物的合成

  摘要：

  通过磺胺与取代的芳族醛缩合获得亚胺衍生物。然后用硼氢化钠还原席夫碱，得到相应的胺，即4-氨磺酰基苯基-苄胺的衍生物。研究了这些磺酰胺作为人碳酸酐酶（hCA，EC 4.2.1.1）同工型hCA I和II（胞质同工酶）以及hCA IX和XII（跨膜，肿瘤相关酶）的抑制剂。我们注意到，与相应的席夫碱相比，掺有仲胺部分的化合物对所有CA同工酶表现出更好的抑制活性。检测到低纳摩尔CA II，IX和XII抑制剂，而针对hCA I的活性较低。结合了磺酰胺或类似锌结合基团的仲胺，

  DOI：

  10.1016/j.bmc.2016.01.020
• 作为产物：
  描述：

  4-甲氧基苯甲醛 、 磺胺 在 silica gel 作用下， 反应 0.13h， 生成 4-[(4-methoxybenzylidene)amino]benzenesulfonamide
  参考文献：
  名称：

  微波辅助，无溶剂和平行合成一些具有生物意义的新型取代的咪唑。

  摘要：

  据报道，无溶剂微波辅助合成了一些具有生物学意义的新型取代的咪唑。首先，将伯芳族或杂胺与芳基或杂醛缩合，得到相应的席夫碱。席夫氏碱进一步用醋酸铵（NH（4）OAC）和靛红使用硅胶作为固体载体处理，得到相应的芳基咪唑。本文介绍了已开发的微波方法与常规方法之间的对比研究。通过物理和分析数据分析了合成的化合物。评价了合成的化合物的抗菌，驱虫，短期抗癌和抗结核活性。所有合成的取代的咪唑均显示出对革兰氏阴性细菌肺炎克雷伯菌和大肠杆菌具有良好的抗菌活性，并具有中等至良好的驱虫活性。合成的咪唑衍生物对Ehrlich腹水癌（EAC）细胞系具有明显的细胞毒活性。这些化合物均未显示出显着的抗结核活性。

  DOI：

  10.1248/cpb.58.375

文献信息

• Design, synthesis, molecular modeling, and biological evaluation of sulfanilamide-imines derivatives as potential anticancer agents
  作者：Sofian S. Mohamed、Abdalkarem R. Tamer、Salah M. Bensaber、Mousa I. Jaeda、Nouri B. Ermeli、Aemen Ali Allafi、Ibrahim A. Mrema、Mabrouk Erhuma、Anton Hermann、Abdul M. Gbaj

  DOI：10.1007/s00210-013-0883-y

  日期：2013.9

  A series of sulfanilamide Schiff base derivatives (1 to 15) have been designed as potential antitubulin agents depending on the chemical structures of combretastatine A-4 and isoquinoline sulfamate (antimitotic agents under investigation). The designed compounds were synthesized by microwave chemical synthesis, their purity was confirmed by melting point and HPLC and chemical structures were determined

  根据考布他汀 A-4 和异喹啉氨基磺酸盐（正在研究的抗有丝分裂剂）的化学结构，一系列磺胺席夫碱衍生物（1 至 15）已被设计为潜在的抗微管蛋白药物。设计的化合物通过微波化学合成合成，其纯度通过熔点和 HPLC 确定，化学结构通过 FT-IR、UV、1H 和 13C-NMR 光谱技术确定。使用分子建模程序将合成的化合物对接在 β-微管蛋白的秋水仙碱结合位点，并通过细胞计数法筛选了对人乳腺癌和肺癌细胞的抗肿瘤活性。一些测试化合物显示出针对乳腺癌 (MCF-7) 的有效和选择性活性，IC50 范围为 90 至 166 μM。关于广谱活动，化合物 4、8 和 13 对人乳腺和人肺细胞显示出有效的抗肿瘤活性，IC50 范围为 96 至 140 μM。所得结果表明磺胺席夫碱衍生物可能构成一类有趣的新型抗癌剂，值得进一步研究。
• Design, Synthesis, and Evaluation of Thiazolidinone Derivatives as Antimicrobial and Anti-viral Agents
  作者：Veerasamy Ravichandran、Abhishek Jain、Krishnan S. Kumar、Harish Rajak、Ram K. Agrawal

  DOI：10.1111/j.1747-0285.2011.01149.x

  日期：2011.9

  acid in dry benzene/toluene. The newly synthesized compounds were characterized on the basis of elemental analysis, IR, 1HNMR, and mass spectra. The newly synthesized final compounds were evaluated for their in vitro antibacterial, antifungal, and anti‐viral activities. Preliminary results indicated that some of the compounds demonstrated antibacterial activity in the range of 7–13 μg/mL, antifungal

  通过各自的芳香胺，芳香醛和巯基乙酸在干苯/甲苯中的反应，制备了一系列1,3-噻唑烷-4-酮衍生物。根据元素分析，IR，1 HNMR和质谱对新合成的化合物进行表征。对新合成的最终化合物进行了体外评估抗菌，抗真菌和抗病毒活性。初步结果表明，与标准药物环丙沙星和氟康唑相比，某些化合物的抗菌活性范围为7–13μg/ mL，抗真菌活性范围为13–17μg/ mL。结构与活性之间的关系研究表明，噻唑烷酮核的2和3位上的取代基的性质对这类药物的体外抗菌和抗病毒活性具有重大影响。
• 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic
  申请人：Sankyo Company, Limited

  公开号：US05908858A1

  公开（公告）日：1999-06-01

  Compounds of formula (I) and (II): ##STR1## \x9bwherein R is hydrogen, halogen or alkyl; R.sup.1 is alkyl, amino or substituted amino; R.sup.2 is optionally substituted phenyl; R.sup.3 is hydrogen, halogen or optionally substituted alkyl; R.sup.4 is hydrogen, optionally substituted alkyl, cycloalkyl, aryl, or aralkyl! have valuable analgesic, anti-inflammatory, anti-pyretic and anti-allergic activities and have the ability to inhibit the production of leukotrienes and to inhibit bone resorption. They are relatively free from the side effects which generally result from the administration of compounds having these kinds of activities.

  式(I)和(II)的化合物：##STR1## 其中R为氢、卤素或烷基；R.sup.1为烷基、氨基或取代氨基；R.sup.2为可选取代的苯基；R.sup.3为氢、卤素或可选取代的烷基；R.sup.4为氢、可选取代的烷基、环烷基、芳基或芳基烷基！具有有价值的镇痛、抗炎、退烧和抗过敏活性，并具有抑制白三烯产生和抑制骨吸收的能力。它们相对于一般具有这些活性的化合物的副作用较少。
• Microwave-assisted, solvent-free, parallel syntheses and elucidation of reaction mechanism for the formation of some novel tetraaryl imidazoles of biological interest
  作者：B. R. Prashantha Kumar、Gyanendra Kumar Sharma、S. Srinath、Mohamed Noor、B. Suresh、B. R. Srinivasa

  DOI：10.1002/jhet.68

  日期：2009.3

  Abstract The microwave assisted, solvent free, parallel syntheses of title compounds is described in this protocol. Twelve new tetraaryl imidazoles, which are incorporated with the chemotherapeutic pharmacophores, have been synthesized by adopting one pot multicomponent reaction. Attempt has been made to investigate the mechanism behind the formation of tetraaryl imidazoles by product identification method. The synthesized compounds were analyzed by physical and analytical data. The synthesized compounds were evaluated for their antibacterial, antitubercular, and short‐term anticancer activity. Compound 13 was found to be the candidate compound to investigate further for its potential anticancer activity. J. Heterocyclic Chem., 46, 278 (2009).
• Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
  作者：Ismail Koyuncu、Ataman Gonel、Abdurrahim Kocyigit、Ebru Temiz、Mustafa Durgun、Claudiu T. Supuran

  DOI：10.1080/14756366.2018.1481403

  日期：2018.1.1

  Selective inhibition with sulphonamides of carbonic anhydrase (CA) IX reduces cell proliferation and induces apoptosis in human cancer cells. The effect on CA IX expression of seven previously synthesised sulphonamide inhibitors, with high affinity for CA IX, as well as their effect on the proliferation/apoptosis of cancer/normal cell lines was investigated. Two normal and three human cancer cell lines were used. Treatment resulted in dose- and time-dependent inhibition of the growth of various cancer cell lines. One compound showed remarkably high toxicity towards CA IX-positive HeLa cells. The mechanisms of apoptosis induction were determined with Annexin-V and AO/EB staining, cleaved caspases (caspase-3, caspase-8, caspase-9) and cleaved PARP activation, reactive oxygen species production (ROS), mitochondrial membrane potential (MMP), intracellular pH (pHi), extracellular pH (pHe), lactate level and cell cycle analysis. The autophagy induction mechanisms were also investigated. The modulation of apoptotic and autophagic genes (Bax, Bcl-2, caspase-3, caspase-8, caspase-9, caspase-12, Beclin and LC3) was measured using real time PCR. The positive staining using gamma-H2AX and AO/EB dye, showed increased cleaved caspase-3, caspase-8, caspase-9, increased ROS production, MMP and enhanced mRNA expression of apoptotic genes, suggesting that anticancer effects are also exerted through its apoptosis-inducing properties. Our results show that such sulphonamides might have the potential as new leads for detailed investigations against CA IX-positive cervical cancers.